ServiceUpdated on 27 January 2025

Due Diligence Assessment

Tabatha Bourgois

Director, Regulatory and Clinical Development at Alira Health

Barcelona, Spain

About

> Report identifying and assessing important regulatory issues of an asset

> Conducted in multiple conditions and stages of development (e.g., FIH, prior to certification), both for licensing and for acquisition

> Provide recommendations on potential regulatory implications and requirements and go/no-go decision from the regulatory perspective

Type

  • Consulting

Organisation

Alira Health

CRO/SMO

Boston, United States

Similar opportunities

  • Service

    Regulatory Strategy

    • Medtech
    • Consulting
    • Biotech and Lifescience

    Tabatha Bourgois

    Director, Regulatory and Clinical Development at Alira Health

    Barcelona, Spain

  • Product

    Elly - Regulatory Affairs Assistant

    • Medtech

    Michael Galliker

    Founder and CEO at Regulatory Globe GmbH

    Oberdorf NW, Switzerland

  • Service

    Clinical Strategy

    • Consulting

    Tabatha Bourgois

    Director, Regulatory and Clinical Development at Alira Health

    Barcelona, Spain